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PRO-OPIOMELANOCORTIN (POMC) codes for several bioac- 
tive peptides. ACTH. alpha-MSH. beta-endorphin, that are im- 
portant not only in the adult neuroendocrine function, but also 
during development (IO, 15, 19, 20. 31, 34. 36, 48). POMC is 
synthesized in both the pituitary gland and the brain (1 I 8, 13, 18. 
24-26, 34). Furthermore, POMC gene expression has been shown 
to occur in the brain as well as the pituitary gland (5, 9. 17. 77- 
30. 43). Developmentally. POMC peptide products are seen very 
early during gestation in the pituitary and brain (2. 4. 7, I I. 21, 
23, 31. 32, 41, 47). Given the known effects of POMC products 
on nerve cell maturation (45), as well as differential posttransla- 
tional processing of POMC during different developmental stages 
(211, it is of interest to investigate the expression of this impor- 
tant precursor and its mRNA during ontogenetic development. 
Thus, in the present study, we present evidence for the co-appear- 
ance of POMC mRNA and therefore gene expression and POMC 
peptide products in the rat pituitary gland as early as the immu- 
nocytochemical detection of POMC in this gland during ontoge- 
netic development. We further study the development of POMC 
mRNA and peptide. throughout prenatal and early postnatal pe- 
riod in this gland. 
METHOD 
Adult male and female Sprague-Dawley rats were used to ob- 
tain timed-pregnant females. One male and three females were 
placed in a cage before 6 p.m., and vaginal smears were exam- 
ined at 8 a.m. the following day for the presence of sperm. The 
first day of detection of sperm in vaginal smear was designated 
day zero of gestation. Pregnant (sperm-positive) rats were placed 
in individual marked cages, and at various time points they were 
sacrificed by cervical dislocation to obtain embryonic rat pups. 
These included emb~onic days E14, El5. El7, and E19. Some 
pregnant rats were kept to term. and the male progeny were sac- 
rificed at the following postnatal days: PI, P7, Pl4, and P21. The 
rat pups were flushed through the heart with 4°C normal saline, 
decapitated, and the head was fixed in 4°C neutral buffered 
paraformaldehyde. The postnatal rats. as well as an adult male 
rat, were sacrificed by intracardiac perfusion of the same fixative. 
and the pituitaries were extracted for further processing. After 
fixation, all tissues were immersed in 20% sucrose (4°C) for 24 
hours. and frozen in liquid nitrogen. Ten micron cryostat sections 
of the pituitary gland were mounted onto polyiysine-coated slides 
and stored at -80%. Some sections were processed for peroxi- 
dase anti-peroxidase immunocytochemistry using an antiserum to 
ACTH (23). Close-by sections (nonadjacent) were processed for 
in situ hybridization histochemistry using a mouse POMC ribo- 
probe (22). 
Sections were incubated (37°C) with an ACTH antise~m (ii 
2000), the cross-reactivities of which have been fully charaeter- 
ized (23,51). After incubation for 1 hour, the slides were placed 
in a moist-box and refrigerated for 24 hours. The sections were 
washed in 0.02 M phosphate-buffered saline (PBS) and incubated 
with goat anti-rabbit serum (111000, Arnel) for 30 minutes fol- 
lowed by refrigeration for 24 hours. After several PBS washes. 
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the sections were incubated successively with anti-horseradish 
peroxidase (anti-HRP), and 4 kg/ml HRP enzyme (Sigma. type 
VI), each for 40 minutes. After PBS rinse, the sections were re- 
acted in a solution of 0.125 mgiml diaminobenzidine (Sigma) and 
0.03% H,O, for 15 minutes at room temperature. The slides were 
then washed in distilled water, dehydrated through ethanols and 
xylenes, and coverslipped in Permount for microscopic obser- 
vations. 
111 Situ Hybridtation 
Mouse POMC cDNA (gift of Dr. J. L. Roberts, Columbia 
University) was subcloned into SP6. A cRNA probe was pre- 
pared using the SP 6 transcription system (Promega). The plas- 
mid was linearized using restriction enzyme Ncol. and was 
transcribed in the presence of SP6 polymerase and [35S]UTP 
yielding a probe of 436 bases (complementary to nucleotides 
479-915 of the mouse POMC cDNA). Labeled cRNA (specific 
activity: 10.94~ lOh Ciimmol) was separated from free label on 
a Sephadex G50 column. Prior to hybridization, sections were 
deproteinated in 0.2 N HCI for I5 minutes and washed in 2 x 
SSC (300 mM NaCI, 30 mM Na citrate). Hybridization buffer 
contained 50%’ formamide, 10% dextran sulfate, 3 X SSC. I x 
Denhardts (0.02% ficoll. 0.02% polyvinyl pyrollidone, 10 kg/ml 
BSA). 100 yg/ml yeast RNA. and 100 @g/ml Salmon perm DNA. 
The [“S]RNA probe (2 million counts: 8.23 x IO- ” mol./slide) 
was applied to each section. coverslipped, edges sealed with rub- 
ber cement, and incubated at 45°C for 24 hours. Control sections 
were incubated with an equal concentration of radiolabeled sense 
strand cRNA which has a sequence identical to that of the mRNA. 
Slides were washed in 2 X SSC. then incubated in RNase A (I 
mg/5 ml in I I mM Tris buffer, 500 mM NaCI) for 30 minutes at 
37°C to reduce nonspecific hybridization. Tissues were washed in 
0.5 x SSC at 45OC for I hour, dried, and processed for autorad- 
iography. Kodak NTB-2 nuclear-track emulsion was melted at 
42°C and diluted in distilled water (v/v). Slides were individually 
dipped, allowed to air-dry in dark. and stored at 4°C from l-5 
days. These were then developed in Kodak D19 developer. dehy- 
drated through ethanols and xylenes. and coverslipped for m- 
croscopy. Observations and photography were performed on a 
Leitz Orthoplan microscope. 
RESULTS 
The ACTH antiserum used in the present study has been ex- 
tensively characterized under immunocytochemical conditions 
(23.51). The antiserum recognizes the ACTH-(20-24) region and 
was not blocked by alpha-MSH, beta-lipotropin. beta-endorphin. 
or Met-enkephalin. For in situ hybridization control, the specific- 
ity of labeling seen with the POMC riboprobe was confirmed by 
the application of equal concentrations of radiolabeled sense strand 
cRNA to the sections. No binding was observed with the sense 
strand probe; this result was expected because the sense strand 
POMC cRNA has the same sequence as that of the POMC mRNA. 
The mouse POMC riboprobe showed high specificity for POMC 
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mRNA. It had distinct advantages over oligonucleotides (cDNA) 
under in situ hybridization conditions. Labeling one out of four 
nucleotides ([35S]UTP) over the entire 436 bases of cRNA yielded 
a probe with higher specific activity when compared to the label- 
ing of much shorter sequences of nick-translated cDNA (3). Since 
RNA-RNA bonds are more stable than DNA-RNA bonds. more 
stringent washing conditions were applied to reduce nonspecific 
background. Lastly, posthybridization digestion with RNase A 
were used to further reduce nonspecific signals. 
Analysis of sections processed for ACTH immunocytochem- 
istry revealed a pattern of staining in the anterior lobe cortico- 
trophs and intermediate lobe cells as previously described by a 
number of investigators (21.41). At the earliest embryonic day 
analyzed, i.e.. E14. no ACTH staining could be detected in ei- 
ther anterior or intermediate lobes of the pituitary gland (Fig. 
IA). At embryonic day E15. a few ACTH immunoreactive cells 
were seen in the anterior lobe, with no immunoreactivity discem- 
able in the intermediate lobe (Fig. IC). By day El7, the pattern 
of ACTH staining changed drastically such that a large number of 
anterior lobe cells and numerous (but not all) intermediate lobe 
cells exhibited immunoreactivity (Fig. IE). At E19, the pattern of 
ACTH immunoreactivity resembled that of the adult pituitary with 
the notable exception that the cells in both lobes were more 
densely packed such that the staining pattern was much denser 
than that normally seen in the adult pituitary (Fig. IG). 
From postnatal days Pl through P2l (data not shown for P7), 
ACTH immunoreactivity in the anterior and intermediate lobes 
matured to more adult-like patterns (Fig. 2A. C, E). The major 
change observed during this period was one of rapid tissue expan- 
sion resulting in an apparent “dilution” of the staining intensity 
in the later stages studied. Finally. the pattern of staining at P21 
was identical to that seen in the adult. save for tissue expansion 
(Fig. 3E. G). 
In situ hybridization histochemical labeling showed a very 
similar pattern of autoradiographic grains to that seen with 
ACTH immunocytochemistry. No autoradiographic label (i.e.. 
no (“S]cRNA-mRNA binding) was seen in the earliest emhry- 
onic days analyzed: at El4 the grain density was not higher than 
background (Fig. IB). However. by EIS. several labeled cells 
could he seen in the anterior lobe, corresponding to the same re- 
gion where immunoreactive ACTH cells reside (Fig. ID). The 
pattern of autoradiographic grain densities over the anterior and 
intermediate lobes at embryonic days El7 and EIY. also mirrored 
the pattern of ACTH staining in these lobes. Labeling became 
increasingly intense over both lobes from El 7 to El9 (Fig. IF, 
H). Postnatally. in situ labeling patterns became progressively 
less intense in the anterior lobe but not the intermediate lobe. At 
PI. grain density over the anterior lobe was lower than that seen 
at El9 (Fig. 2B). Likewise. at P7 (data not shown). Pl3. and 
P2 I, and in the adult. autoradiographic grain density over the an- 
terior lobe was less intense when compared to embryonic patterns 
of labeling (Fig. 2D. F, H). This diminution of label with in- 
creasing age corresponded well with the progressively less in- 
tense ACTH staining observed under immunocytochemical 
conditions. a phenomenon attributable perhaps to general tissue 
expansion with increasing age. 
FIG. I. Parasagmal sections through the rat pituitary gland on embryonic days El4 (A and B). El5 (C and D), El7 (E and F). and El9 (G and H). 
These sections were processed for ACTH immunocytochemistry (A, C. E. G), and in situ hybridization histochemistry using a POMC cRNA (B. D. F. 
H). Note that no ACTH immunoreactivity or specific autoradiographic grains can be seen in either anterior lobe (AL) or intermediate lobe (IL) at E 14, 
but at El5 numerous ACTH cells as well as autoradiographic grains over cells (arrows) can be seen in the same region of the AL. At El 7 and E 19, 
ACTH immunoreactivity and autoradiographic grains in both the AL and IL are very intense. RP = Rathke’s pouch. Magnification for all sections: Bar 
(in A) = 50 km. 
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FIG. 2. Horizontal sections through the rat pituitary gland on postnatal days PI (A and B). PI4 (C and D), P21 (E and F), and in the adult (G and H). 
Sections A. C. E. and G. were processed for ACTH immunocytochemistry. Sections B. D. F, and H, were processed for in $itu hybridization 
histochemibtry using a POMC cRNA. Note that the intensity of ACTH immunoreactivity per unit area of the anterior lobe (AL) is propressively dimin- 
ished from PI to P21 and in the adult. In parallel to this, the autoradiographic grain density over the AL cells becomes procgressively less intense during 
the same time period. IL = intermediate lobe. Magnification for all sections: Bar iin A) = 50 km. 
In the present study. we have shown that POMC mRNA ex- 
pression as determined by in situ hybridization histochemistry. 
and POMC peptide expression as observed by ACTH immunocy- 
tochemistry. are parallel events in both the pituitary anterior and 
intermediate lobes during prenatal and early postnatal develop- 
ment in the rat. ACTH immunoreactivity was used as a marker 
for POMC synthesis. since this peptide, along with alpha-MSH, 
beta-endorphin and others are all derived from POMC and are 
co-stored in the same cells of the pituitary (6. 38. 52). Further- 
more, the ACTH antiserum has been characterized under immu- 
nocytochemical conditions (23.5 1). The mouse POMC riboprobe 
used in these studies binds with high specificity to POMC mRNA. 
It has distinct advantages over oligonucleotides (cDNA) under in 
situ hybridization conditions. Labeling one out of four nucleotides 
([‘“SIIJTP) over the entire 436 bases of cRNA yields a probe 
with higher specific activity when compared to the labeling of 
much shorter sequences of nick-translated cDNA (3). Further- 
more, RNA-RNA bonds are more stable than DNA-RNA bonds, 
and therefore more stringent washing conditions can be applied to 
reduce nonspecific background. Lastly, posthybridization diges- 
tion with RNase .4 can further reduce nonspecific signals due to 
single-stranded probe “stickiness” to tissue. The control condi- 
tions used in this study consisted of the application of equal con- 
centrations of radiolabeled sense strand cRNA to the sections. 
Since the sense strand POMC cRNA has the same sequence as 
that of the POMC mRNA. no binding was observed, confirming 
the specificity of the in situ labeling seen with the POMC ribo- 
probe. 
Numerous studies have addressed the development of the POMC 
precursor and its peptides during prenatal and postnatal develop- 
ment (2, 4. 7, I I. 14. 21, 23. 3 1. 32, 41, 47). All of these stud- 
ies are in agreement that POMC peptides occur very early in both 
pituitary and brain during development. For example, beta-endor- 
phin. and ACTH immunoreactivity are seen in the rat hypothala- 
mus as early as embryonic day El2 (21,41). The appearance of 
POMC peptides in the pituitary, however, is comparatively de- 
layed until embqonic day E15. Nevertheless, POMC peptides 
are among the earliest peptidergic systems to develop during on- 
togeny. Even among the opioid peptides, POMC products are 
seen earlier in both brain and pituitary when compared to either 
the pro-enkephalin or pro-dynorphin peptides (2, 4, 16, 21, 35. 
77, 39. 42, 50). The significance of early POMC synthesis dur- 
ing ontogenetic development has been explored by several inves- 
tigators. For example, alpha-MSH and other ACTH fragments 
have been shown to stimulate nerve cell maturation, and thus 
might fit into the category of neurotrophic substances (45). Fur- 
thermore. in the adult rat brain. there is evidence for differences 
in posttranslational processing of POMC in different regions, an 
observation that ih consistent with the known posttranslational 
processing differences in POMC between the two lobes of the pi- 
tuitary (12.13). Acetylation of ACTH fragments in the adult in- 
termediate lobe to yield alpha-MSH is one such example. This 
process is apparently indigenous to the intermediate lobe cells 
and occurs readily in the anterior lobe as well as during prenatal 
and early postnatal development (2 I ). Yet the significance of this 
early ontogenetic processing of ACTH in the intermediate lobe 
can only be appreciated when taken in light of the evidence that 
developing adrenal cortical cells respond to alpha-MSH but not 
ACTH during early ontogeny (44). 
POMC mRNA has been shown to occur in the pituitary of 
several mammalian species including rat. cat, pig. bull, and man 
(5, 9. 17, 27-29. 43). The pattern of labeling is identical to that 
which is seen using POMC peptide immunocytochemistry. i.e., 
all the intermediate lobe cells and scattered anterior lobe corti- 
cotrophs exhibit autoradiographic labeling. During development, 
there is further evidence that POMC mRNA is present in the 
Rathke’s pouch (embryonic anlage of the pituitary gland) as early 
as embryonic day E13-El5 localized primarily to the rat anterior 
lobe (22. 30. 40). Lugo et al. (30) have further noted that POMC 
mRNA detection preceded the detection of POMC peptide by 0.5 
day. The discrepancy in our previous observations (22) and those 
of Lugo et al. (30) can perhaps be attributed to the differences in 
birth-dating techniques used to obtain timed-pregnant rats. A re- 
cent study of the prenatal ontogeny of POMC in the mouse pitu- 
itary gland also showed peptide and mRNA expression very early 
in this gland (14). Conversely. studies of prolactin and growth 
hormone mRNA expression have shown a much later prenatal 
(E 19) maturation pattern for both of these hormones in the rat pi- 
tuitary gland (33,46). The present study establishes the parallel 
development of POMC peptide immunoreactivity and POMC gene 
expression in the pituitary anterior and intermediate lobes begin- 
ning on embryonic day E15, and reaching adult-like patterns hy 
postnatal day P2 i 
Postnatally. from Pl to P21. both peptide and mRNA label- 
ing was progressively diminished in intensity in the pituitary an- 
terior lobe but not the intermediate lobe. This can best be explained 
in terms of rapid tissue expansion in the same period of time. thus 
making the label per unit area appear less intense with advancing 
age. In the intermediate lobe, mRNA labeling continued to in- 
crease slightly in density throughout postnatal ages studied, con- 
sistent with the findings of ofher investigators (49). 
Finally, the observation that both in situ hybridization his- 
tochemistry and immunocytochemistry detect mRNA and peptide 
labeling. respectively, on the same embryonic day (i.e.. EIS). 
suggests that POMC gene transcription and subsequent translation 
occur within a very short time in the pituitary gland during em- 
bryogenesis. It is important to note that the results of the present 
study were expected since POMC peptide expression and mRNA 
expression have already been shown independently to first occur 
in embryonic pituitary cells at approximately the same gestational 
age (21. 22. 40). Furthermore, this study does not specifically 
pinpoint the exact time of either POMC mRNA or peptide expreb- 
sion. Rather. this study confirms the functional status of peptide- 
synthesizing apparatus within POMC cells at the same time when 
the POMC gene is transcribed into mRNA. 
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